Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$10,784 Mln
P/E Ratio
774.36
P/B Ratio
9.37
Industry P/E
--
Debt to Equity
0.19
ROE
0.01 %
ROCE
1.01 %
Div. Yield
0 %
Book Value
29.31
EPS
0.36
CFO
$44.61 Mln
EBITDA
$247.81 Mln
Net Profit
$151.46 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Penumbra (PEN)
| 26.23 | 4.73 | 9.38 | 45.42 | 17.08 | 9.55 | -- |
|
BSE Sensex
| 1.23 | 1.57 | 3.97 | 7.26 | 11.47 | 20.39 | 11.18 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Penumbra (PEN)
| -5.55 | 13.07 | -22.57 | 64.18 | 6.53 | 34.43 | 29.68 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 12.93 | 10,562.04 | 12.43 | 12.69 | |
| 72.80 | 9,636.16 | 93.23 | 2.52 | |
| 65.17 | 8,023.31 | 21.13 | 11.07 | |
| 163.74 | 8,533.78 | -- | -25.23 |
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral thrombectomy products, including the Indigo System for power... aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, and aspiration pump under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as detachable coils to treat patients with a wide range of neurovascular lesions under the Penumbra SMART COIL and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California. Address: One Penumbra Place, Alameda, CA, United States, 94502 Read more
Co-Founder, Chairman, President & CEO
Mr. Adam Elsesser
Co-Founder & Director
Dr. Arani Bose M.D.
Headquarters
Alameda, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Penumbra Inc (PEN) stood at $ 1,533 Mln as on 31-Dec-24
The share price of Penumbra Inc (PEN) is $299.78 (NYSE) as of 25-Apr-2025 16:20 EDT. Penumbra Inc (PEN) has given a return of 17.08% in the last 3 years.
Penumbra Inc (PEN) has a market capitalisation of $ 10,784 Mln as on 24-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/E ratio of Penumbra Inc (PEN) is 774.36 times as on 24-Apr-2025.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Penumbra Inc (PEN) and enter the required number of quantities and click on buy to purchase the shares of Penumbra Inc (PEN).
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, and aspiration pump under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as detachable coils to treat patients with a wide range of neurovascular lesions under the Penumbra SMART COIL and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California. Address: One Penumbra Place, Alameda, CA, United States, 94502
The CEO & director of Mr. Adam Elsesser. is Penumbra Inc (PEN), and CFO & Sr. VP is Dr. Arani Bose M.D..
There is no promoter pledging in Penumbra Inc (PEN).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,054
|
|
|
964
|
|
|
853
|
|
|
802
|
| Penumbra Inc. (PEN) | Ratios |
|---|---|
|
Return on equity(%)
|
1.2
|
|
Operating margin(%)
|
1.87
|
|
Net Margin(%)
|
1.17
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Penumbra Inc (PEN) was $0 Mln.
$1.53
(
